1.
Hanumant Gambhire, Monica Gulati, Sachin Kumar Singh, Atul Nasa, Neelu Goel. AN OVERVIEW OF US FDA WARNING LETTERS TO INDIAN PHARMACEUTICAL INDUSTRIES FOR cGMP VIOLATIONS PERTAINING TO STERILE PRODUCTS. J Popl Ther Clin Pharmacol [Internet]. 2022 Aug. 20 [cited 2024 Nov. 18];29(03):1845-63. Available from: https://mail.jptcp.com/index.php/jptcp/article/view/7242